The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasms

Br J Haematol. 2008 May;141(4):557-8. doi: 10.1111/j.1365-2141.2008.07034.x. Epub 2008 Mar 26.

Authors

Eleftheria Hatzimichael, Aggeliki Dasoula, Leonidas Benetatos, Alexandros Makis, Justin Stebbing, Tim Crook, Maria Syrrou, Konstantinos L Bourantas

PMID: 18371112
DOI: 10.1111/j.1365-2141.2008.07034.x

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Cyclin-Dependent Kinase Inhibitor p57 / genetics*
DNA Methylation*
DNA, Neoplasm / genetics
Female
Humans
Male
Middle Aged
Multiple Myeloma / genetics
Neoplasms, Plasma Cell / genetics*

Substances

CDKN1C protein, human
Cyclin-Dependent Kinase Inhibitor p57
DNA, Neoplasm